NASDAQ · MRVI
Maravai LifeSciences Holdings, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for MRVI: Nov 04, 2026
Maravai LifeSciences Holdings, Inc. Class A Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.07. The reported EPS for the same quarter last year was $-0.14.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.07 | $-0.07 | $-0.08 | 3 |
| Dec 2026 | $-0.05 | $-0.04 | $-0.05 | 2 |
| Mar 2027 | $0.01 | $0.01 | $0.01 | 1 |
| Jun 2027 | $-0.02 | $-0.02 | $-0.02 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · BNK Invest · Zacks · RTTNews- Fintel · Oct 23, 3:20 AM EDTMaravai LifeSciences Holdings Consensus Price Target Increased 11.84% to $8.67The average one-year price target for Maravai LifeSciences Holdings (NASDAQGS:MRVI) (DB:MAR) has been revised to $8.67 / share. This is an increase of 11.84% from the prior estimate of $7.75 dated September 29, 2026. These figures represent aggregate analyst targets compiled from
- BNK Invest · Sep 25, 6:49 AM EDTMRVI Crosses Above Average Analyst TargetIn recent trading, shares of Maravai LifeSciences Holdings Inc (Symbol: MRVI) have crossed above the average analyst 12-month target price of $7.42, changing hands for $7.65/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: d
- Zacks · Sep 25, 6:34 AM EDTPerrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?Perrigo (PRGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- RTTNews · Aug 20, 4:21 AM EDTBiotech Stocks At 52-Week Highs – MRNA Surges +176% On Phase 3 Data, SCTV, MRVI, SOPH, IMNM(RTTNews) – The following biotech stocks reached a 52-week high on August 19, 2026, primarily driven by positive clinical research results and promising quarterly reports.
- The Motley Fool · Aug 13, 8:16 PM EDTMaravai (MRVI) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 7, 1:04 AM EDTMaravai LifeSciences Q2 Earnings Call HighlightsMaravai LifeSciences (NASDAQ:MRVI) reported second-quarter 2026 revenue growth and a sharp improvement in adjusted profitability, while maintaining its full-year revenue outlook and raising its adjusted EBITDA forecast. Revenue for the quarter was $51.4 million, up 9% from the p
- Zacks · Aug 6, 5:40 PM EDTMaravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue EstimatesMaravai LifeSciences (MRVI) delivered earnings and revenue surprises of +60.00% and +4.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Jul 24, 6:29 AM EDTBiotech Stocks At 52-Week Highs – MEDP And NVCR Rise With Positive Q2 Reports, ETON, MRVI, ADVB(RTTNews) – The following biotech stocks reached a 52-week high on July 22, 2026, following key catalysts such as positive quarterly reports and anticipated clinical trial readouts.
- RTTNews · Jul 16, 4:19 AM EDTBiotech Stocks At 52-Week Highs – CPIX, MRVI, ANGO, ACHC, TDOC(RTTNews) – The following biotech stocks reached a 52-week high on July 15, 2026, driven by catalysts such as recent business developments or positive quarterly reports.
- NASDAQ.com · Jul 14, 4:24 PM EDTAfter Hours Most Active for Jul 14, 2026 : PFE, NVDA, CRWV, QXO, SPCE, CSCO, RKT, AAPL, SEI, MRVI, VALE, PDBCThe NASDAQ 100 After Hours Indicator is up 1.55 to 29,587.84. The total After hours volume is currently 147,417,977 shares traded.The following are the most active stocks for the after hours session: Pfizer, Inc. (PFE) is +0.0026 at $24.25, with 9,011,062 shares traded. PFE's cu
- Fintel · May 14, 6:12 AM EDTMaravai LifeSciences Holdings (MRVI) Price Target Increased by 23.91% to 5.81The average one-year price target for Maravai LifeSciences Holdings (NasdaqGS:MRVI) has been revised to $5.81 / share. This is an increase of 23.91% from the prior estimate of $4.69 dated April 25, 2026. The price target is an average of many targets provided
- The Motley Fool · May 9, 4:35 PM EDTMaravai (MRVI) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Maravai LifeSciences Holdings, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.